Hyponatremia in children with tuberculous meningitis: A hospital-based cohort study

Prithi Inamdar1, Sanjeevani Masavkar2, Preeti Shanbag3

  • 1Department of Pediatrics, Jawaharlal Nehru Medical College, Belgaum, Karnataka, India.

Insights

Cerebral salt wasting syndrome (CSWS) is a significant cause of hyponatremia in children with tuberculous meningitis (TBM). This study found CSWS more common than SIADH in pediatric TBM patients with hyponatremia.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Endocrinology

Background:

  • Hyponatremia is a common complication in pediatric tuberculous meningitis (TBM), affecting 35-65% of children.
  • Syndrome of inappropriate antidiuretic hormone (SIADH) secretion was previously considered the primary cause of hyponatremia in TBM.
  • Cerebral salt wasting syndrome (CSWS) is increasingly recognized as a potential cause of hyponatremia in TBM.

Purpose of the Study:

  • To determine the incidence and etiological factors of hyponatremia in children diagnosed with TBM.
  • To differentiate between SIADH and CSWS as causes of hyponatremia in this pediatric population.

Main Methods:

  • Prospective study of children with newly diagnosed TBM over two years.
  • Monitoring of clinical and laboratory parameters including serum electrolytes, urine output, and urinary sodium.
  • Diagnosis of hyponatremia (<135 mEq/L), CSWS (volume depletion, natriuresis), and SIADH.

Main Results:

  • Hyponatremia occurred in 38.7% (29/75) of children with TBM.
  • Discontinuation of mannitol resolved hyponatremia in 19 patients.
  • Persistent hyponatremia was attributed to CSWS in 10 patients; no cases of SIADH were identified.

Conclusions:

  • CSWS is a significant cause of hyponatremia in children with newly diagnosed TBM.
  • CSWS was observed more frequently than SIADH in this cohort of pediatric TBM patients.
  • These findings highlight the importance of considering CSWS in the management of hyponatremia in pediatric TBM.
Abstract

Related Concept Videos

Tonicity in Animals01:16

Tonicity in Animals

Tonicity describes the amount of solute in a solution. The measure of the tonicity of a solution, or the total amount of solutes dissolved in a specific amount of solution, is called its osmolarity. Three terms—hypotonic, isotonic, and hypertonic—are used to relate the osmolarity of a cell to the osmolarity of the extracellular fluid that contains the cells. In a hypotonic solution, such as tap water, the extracellular fluid has a lower concentration of solutes than the fluid inside...
8.6K
Tonicity in Animals00:59

Tonicity in Animals

The tonicity of a solution determines if a cell gains or loses water in that solution. The tonicity depends on the permeability of the cell membrane for different solutes and the concentration of nonpenetrating solutes in the solution within and outside of the cell. If a semipermeable membrane hinders the passage of some solutes but allows water to follow its concentration gradient, water moves from the side with low osmolarity (i.e., less solute) to the side with higher osmolarity (i.e.,...
127.9K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
346
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
726
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
660